pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Hepatology · news · pharmadog
← back to Hepatology
News · Hepatology
262
stories
Jul 28, 26
GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ's backyard
fiercebiotech
Jul 28, 26
STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD
stat
Jul 24, 26
Amgen sheds around 40 staffers amid continuing struggles
fiercebiotech
Jul 24, 26
Ipsen’s Bylvay fails key trial in children with rare liver disease
endpoints
Jul 24, 26
Amgen deploys patients to defend troubled Tavneos in FDA hearing request
biospace
Jul 22, 26
Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug
biopharma dive
Jul 22, 26
House passes bill directing FDA to update animal testing rules
fiercebiotech
Jul 20, 26
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
biospace
Jul 16, 26
Pete Hegseth’s announcement of annual testosterone screenings for service members divides medical experts
stat
Jul 15, 26
Cassidy grills Trump nominee on past vaccine comments in heated exchange
stat
Jul 14, 26
Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill
biopharma dive
Jul 14, 26
STAT+: Akero team, backed by Fairmount, launches new immunology company
stat
Jul 14, 26
FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientist
stat
Jul 14, 26
12 ideas for tackling the U.S. alcohol epidemic
stat
Jul 10, 26
Nominee for key federal health role has a history of questioning vaccines
stat
Jul 10, 26
FDA rejects Hengrui-Elevar liver cancer drug combo for third time
endpoints
Jul 10, 26
FDA quietly pushes back deadline on electric shock ban
stat
Jul 8, 26
Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says
stat
Jul 8, 26
STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam Therapeutics
stat
Jul 7, 26
Kailera says obesity pill succeeds in late-stage trial in China
biopharma dive
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 15, 26
FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes
fda press
Jun 11, 26
HHS responds coolly to paper on alcohol risk
stat
Jun 9, 26
Gilead and Merck’s latest trial success and flop
stat
Jun 9, 26
Alcohol study discarded by Trump officials is published in scientific journal
stat
Jun 8, 26
STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
stat
Jun 8, 26
City banks nearly $100M for next-gen RNAi drugs
biopharma dive
Jun 8, 26
City Therapeutics gets $99M to gather data on three RNAi medicines
endpoints
Jun 8, 26
GSK inks multi-target pact with Engitix; Sangamo considers strategic options
endpoints
← prev
page 7 of 9
next →